Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.
about
Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alphaPerfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USAAssociation between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination SurveyExposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of ageCorrelations between prenatal exposure to perfluorinated chemicals and reduced fetal growthPrenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancyDevelopmental neurotoxicity of perfluorinated chemicals modeled in vitroExposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in SwedenCord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birthHistorical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human bloodPerfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.Effects of Environmental Exposures on Fetal and Childhood Growth TrajectoriesFetal and neonatal endocrine disruptorsPerfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma InactivationPhenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanismsThyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuumPerfluorinated compounds in umbilical cord blood and adverse birth outcomesBinding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals.Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort studyDietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway.Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS)Loss and in situ production of perfluoroalkyl chemicals in outdoor biosolids-soil mesocosms.Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues.Carcinogenic potency of perfluorooctane sulfonate (PFOS) on Syrian hamster embryo (SHE) cells.Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha.Perfluoroalkyl contaminants in plasma of five sea turtle species: comparisons in concentration and potential health risks.Perfluoroalkyl acids: a review of monitoring and toxicological findings.Effects of perfluoroalkyl compounds on mRNA expression levels of thyroid hormone-responsive genes in primary cultures of avian neuronal cells.Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort studyPregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years--a prospective studyPerfluorooctane sulfonate disturbs Nanog expression through miR-490-3p in mouse embryonic stem cells.Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study.Perfluorochemical (PFC) exposure in children: associations with impaired response inhibitionAttention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurementsPerfluorinated alkyl acids in the plasma of South African crocodiles (Crocodylus niloticus).Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers.Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action
P2860
Q23914416-347C2341-E79F-4EFA-A266-4C67741593E1Q24530138-09612C97-D7EC-433A-B776-53CB3BF995F9Q24617552-4A816369-66D8-462C-89AA-847496DFEAB5Q24624507-C7B4BB6A-9325-4EC7-B75B-99DD2CCF8E1FQ24629288-3045BE58-FFAE-41B9-88F0-5C999E02FB22Q24647791-EBB48B28-4C7F-4422-A74C-D84448EBBCFAQ24651358-4895C809-13E5-4852-A673-1C6D8B2E4832Q24654096-4C082CC4-B20D-41DF-AF07-2B8D6DC0B05EQ24676545-B8E1D915-EF82-4A13-A9C2-CA24AC415DA7Q24680500-945F2DFE-91E3-4FFD-8CF7-88214CF655D6Q24812835-843949E0-BEE3-478F-8A29-5C7BC7DA9D66Q24815415-A3B67F1F-E7E5-4E20-850B-906B3F2A2374Q28079540-B5EA26F4-31EB-4577-95B8-0089220665E1Q28385934-575A1219-52DF-40E5-A48E-8B8D6859BD1DQ28394126-0CBB2AC8-99AC-4A64-913F-C75FB8B819A7Q28530398-179176A1-4CF6-4F56-96CC-AF72B1ACA8F4Q30241400-D933AA48-8C27-4363-AD2D-7FA5C3695A8EQ31077485-82C1EFB2-159D-402F-9191-77C3D7908EF3Q31083691-BB432DCD-3F45-486E-955C-C607023784FFQ33412023-F110F848-C16D-4AFD-B766-708A4D7690FFQ33584961-E75DA094-CE9D-42CF-A1A1-F043B7FE9962Q33606598-D23300A2-7CDF-4DB1-A2DE-E560A211722BQ33637885-A2D80FAB-184C-4A6A-BE0F-0225FD75841BQ34005377-2CD79893-A0D4-45F5-B5DD-2552D506C38EQ34035410-AB355C53-CEFE-4210-9F44-DA6407EFB491Q34068266-6F0C4BDE-963B-4CBC-BCFC-F57C77F28868Q34169970-0B497C00-5459-4136-90E7-7A06C0431FDDQ34207883-3B2D251C-C792-4D5D-97BD-AAA020F0D1ABQ34630884-8FB984CB-CDAB-4632-96E9-2370B0D5B204Q34701773-1ABEBAF4-CF75-42A5-BC64-76F329DD0A69Q34940449-DC9B5A02-685F-491D-ADA4-8A89A32C112EQ34981222-8D4A1B02-B456-4780-AE0D-126B72EE8FE6Q35009042-0E276E9D-18D2-4ADB-84B5-7F47637B2DBDQ35076573-086E3EFA-753F-44D3-8335-F4F5753962F0Q35249221-DE25128B-F012-40F8-A7E7-4ACC0E3051FFQ35250864-2D52E424-DEBD-4744-B54B-C81FDAB80905Q35544436-9117566B-6362-4B19-9D67-2E091A4EEA5EQ35977905-FDAB0BFA-96A4-46AD-B09D-6945826609F1Q36012692-1BF4F5E5-1B52-486C-9F45-8F22D058C69CQ36104027-543D52C1-A6AB-4A22-8BA2-4B020C06A30B
P2860
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@en
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@nl
type
label
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@en
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@nl
prefLabel
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@en
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@nl
P2093
P2860
P356
P1476
Exposure to perfluorooctane su ...... use. II: postnatal evaluation.
@en
P2093
Brian E Grey
Christopher Lau
John L Butenhoff
John M Rogers
Julie R Thibodeaux
Lisa A Stevenson
Mark E Stanton
Roger G Hanson
P2860
P304
P356
10.1093/TOXSCI/KFG122
P577
2003-05-28T00:00:00Z